UNSPSC 51123801: Meobentine sulfate

This classification denotes an antiarrhythmic agent with the molecular formula 2C11H17N3O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D6BKO039M0, chemically known as 1-(p-methoxybenzyl)-2,3-dimethylguanidine sulfate (2:1) but more generally known as meobentine sulfate, which bears US NIH Compound Identifier 42764. Most nations, for tariff and trade purposes, schedule meobentine sulfate under HS 29252900 and SITC 51482. As of Q4 2014, MEOBENTINE SULFATE remains US FDA's Preferred Term for this commodity.

Meobentine sulfate bears US NLM identifiers UMLS ID C0127535 and NCI Concept Code C90664. SMILES: CNC(=NC)NCC1CCC(CC1)OC.CNC(=NC)NCC1CCC(CC1)OC.OS(=O)(=O)O.

UNSPSC 51123801 Meobentine sulfate is a Commodity code representing pharmaceutical active ingredients and finished formulations procured by state and local health agencies, primarily fire-rescue services, health and human services departments, and cooperative purchasing alliances. State and local governments use this code to acquire emergency medications, life-support pharmaceuticals, and generic multi-source drugs for distribution across public health systems, emergency response teams, and institutional care facilities. The work spans sealed competitive bidding for finished pharmaceutical goods (vials, injections, tablets) with firm pricing, expiration-date warranties, and rapid delivery requirements; cooperative purchasing agreements that establish pricing frameworks across multiple state and local member jurisdictions; and strategic market research to evaluate direct-to-manufacturer distribution models that bypass traditional pharmacy benefit managers and group purchasing organizations.

Recent activity shows solicitation spread across fire-rescue procurement in Florida, multistate cooperative purchasing in Minnesota (serving Minnesota and Oregon), and exploratory state-level procurement in Texas. The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 seeking Advanced Life Support Medications (Labetalol, Epinephrine, Adenosine, and Diltiazem) for Tampa Fire Rescue with a due date of April 8, 2026 and an estimated contract value of $40,000—structured with a one-year base term, two one-year renewal options, and unilateral extension rights for up to three additional 30-day periods, plus a 5 percent bid discount for Small Local Business Enterprises not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring vendors to maintain relationships with three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment models, signaling exploratory procurement strategy development for future formal solicitation.